Who should attend?

This conference will be attended by directors, heads and managers working in the pharmaceutical industry in the following departments: Pharmacovigilance Drug Safety Risk management and surveillance Qualified person Medical affairs Quality specialist Clinical safety Chief Scientific Officer Chief Medical Officer Regulatory Aff

Details

The in-depth drug safety conference programme covers the detection, analysis and prevention of adverse drug reactions with case studies and industry experiences as well as global regulatory coverage of developments in the US, Japan, Europe, Asia/Pacific, South America and Canada.

Speakers include:

Susan Graver

Group Director - Global Pharmacovigilance and Epidemiology

Bristol-Myers Squibb



Prof Philippe Van der Auwera

Global Head of Safety Risk Management and EU-QPPV

F-Hoffman La Roche



Dr Beverley Forsythe

Principal Safety Physician R&D, Clinical Development, Patient Safety

AstraZeneca



Dr Larry Johnson

Executive Director, Global Safety Head of Therapeutic Area Safety

Amgen

 

Prices

Early bird discount offer ends 25 June 2010

Contact

Katie Barden
kbarden@healthnetworkcommunications.com